During the past decade, Palo Alto Medical Foundation Research Institute conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Palo Alto Medical Foundation Research Institute" #1 sponsor was "Celgene" with 3 trials, followed by "Hennepin Healthcare Research Institute" with 2 trials sponsored, "University of North Carolina, Chapel Hill" with 2 trials sponsored, "Berkeley Analytics, Inc." with 1 trials sponsored and "California Pacific Medical Center Research Institute" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Palo Alto Medical Foundation Research Institute" #1 collaborator was "Palo Alto Medical Foundation" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Berman Center for Outcomes and Clinical Research" with 2 trials as a collaborator and "Monash University" with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Palo Alto Medical Foundation Research Institute" are "Crohn Disease" (3 trials), "Cancer" (2 trials), "Obesity" (2 trials), "Bleeding" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Palo Alto Medical Foundation Research Institute" in a lesser frequency.

Most popular intervention types in "Palo Alto Medical Foundation Research Institute" are "Behavioral" (9 trials), "Drug" (6 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ozanimod" (3 trials), "100 mg enteric-coated aspirin" (1 trials), "Alive-PD" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Palo Alto Medical Foundation Research Institute" are 11 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Palo Alto Medical Foundation Research Institute". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Palo Alto Medical Foundation Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Palo Alto Medical Foundation Research Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".